Article
A proprietary GMP human platelet lysate for the expansion of dermal fibroblasts for clinical applications
3 Jan 2021
Abstract excerpt
Recent years have witnessed the introduction of ex vivo expanded dermal fibroblasts for several cell therapy and tissue-engineering applications, including the treatment of facial scars and burns, representing a promising cell type for regenerative medicine. We tested different in-house produced human platelet lysate (HPL) solutions against fetal bovine serum as supplements for in vitro fibroblast expansion by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
